(Q40779596)

English

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

0 references

follicular lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nicola Di Gaetano

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Martino Introna

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Y Xiao

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Erba

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Bassan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Rambaldi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

800-809

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Homologous and heterologous desensitization of proto-oncogene cfos expression in murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40779596&oldid=1561097217"